
<resource xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:datacite="http://datacite.org/schema/kernel-4" xmlns="http://namespace.openaire.eu/schema/oaire/" xsi:schemaLocation="http://namespace.openaire.eu/schema/oaire/ https://www.openaire.eu/schema/repo-lit/4.0/openaire.xsd">
  
<datacite:identifier identifierType="URL">https://phaidra.vetmeduni.ac.at/o:4027</datacite:identifier>

  
<datacite:titles>
  
<datacite:title xml:lang="en">Anti-Cancer Potential of a new Derivative of Caffeic Acid Phenethyl Ester targeting the Centrosome</datacite:title>

  
</datacite:titles>

  
<datacite:creators>
  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Giordano, Catello</datacite:creatorName>

  
<datacite:givenName>Catello</datacite:givenName>

  
<datacite:familyName>Giordano</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Kendler, Jonatan</datacite:creatorName>

  
<datacite:givenName>Jonatan</datacite:givenName>

  
<datacite:familyName>Kendler</datacite:familyName>

  
<datacite:affiliation>University of Veterinary Medicine Vienna</datacite:affiliation>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Sexl, Maximilian</datacite:creatorName>

  
<datacite:givenName>Maximilian</datacite:givenName>

  
<datacite:familyName>Sexl</datacite:familyName>

  
<datacite:affiliation>University of Veterinary Medicine Vienna</datacite:affiliation>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Kollman, Sebastian</datacite:creatorName>

  
<datacite:givenName>Sebastian</datacite:givenName>

  
<datacite:familyName>Kollman</datacite:familyName>

  
<datacite:nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/">0000-0001-7911-9896</datacite:nameIdentifier>

  
<datacite:affiliation>University of Veterinary Medicine Vienna</datacite:affiliation>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Varenicja, Maxim</datacite:creatorName>

  
<datacite:givenName>Maxim</datacite:givenName>

  
<datacite:familyName>Varenicja</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Szabó, Boglárka</datacite:creatorName>

  
<datacite:givenName>Boglárka</datacite:givenName>

  
<datacite:familyName>Szabó</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Timelthaler, Gerald</datacite:creatorName>

  
<datacite:givenName>Gerald</datacite:givenName>

  
<datacite:familyName>Timelthaler</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Kirchhofer, Dominik</datacite:creatorName>

  
<datacite:givenName>Dominik</datacite:givenName>

  
<datacite:familyName>Kirchhofer</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Hollóczki, Oldamur</datacite:creatorName>

  
<datacite:givenName>Oldamur</datacite:givenName>

  
<datacite:familyName>Hollóczki</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Turner, Suzanne D.</datacite:creatorName>

  
<datacite:givenName>Suzanne D.</datacite:givenName>

  
<datacite:familyName>Turner</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Moriggl, Richard</datacite:creatorName>

  
<datacite:givenName>Richard</datacite:givenName>

  
<datacite:familyName>Moriggl</datacite:familyName>

  
<datacite:nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/">0000-0003-0918-9463</datacite:nameIdentifier>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Kenner, Lukas</datacite:creatorName>

  
<datacite:givenName>Lukas</datacite:givenName>

  
<datacite:familyName>Kenner</datacite:familyName>

  
<datacite:nameIdentifier nameIdentifierScheme="ORCID" schemeURI="https://orcid.org/">0000-0003-2184-1338</datacite:nameIdentifier>

  
<datacite:affiliation>University of Veterinary Medicine Vienna</datacite:affiliation>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Touaibia, Mohamed</datacite:creatorName>

  
<datacite:givenName>Mohamed</datacite:givenName>

  
<datacite:familyName>Touaibia</datacite:familyName>

  
</datacite:creator>

  
<datacite:creator>
  
<datacite:creatorName nameType="Personal">Merkel, Olaf</datacite:creatorName>

  
<datacite:givenName>Olaf</datacite:givenName>

  
<datacite:familyName>Merkel</datacite:familyName>

  
</datacite:creator>

  
</datacite:creators>

  
<dc:publisher>Elsevier</dc:publisher>

  
<resourceType resourceTypeGeneral="literature" uri="http://purl.org/coar/resource_type/c_6501">journal article</resourceType>

  
<datacite:rights rightsURI="http://purl.org/coar/access_right/c_abf2">open access</datacite:rights>

  
<dc:language>eng</dc:language>

  
<dc:description xml:lang="en">Anaplastic Large Cell Lymphoma (ALCL) is an aggressive T-cell lymphoma affecting children and young adults. About 30% of patients develop therapy resistance therefore new precision medicine drugs are highly warranted. Multiple rounds of structure-activity optimization of Caffeic Acid Phenethyl Ester have resulted in CM14. CM14 causes upregulation of genes involved in oxidative stress response and downregulation of DNA replication genes leading to G2/M arrest and subsequent apoptosis induction. In accordance with this, an unbiased proteomics approach, confocal microscopy and molecular modeling showed that TUBGCP2, member of the centrosomal ?-TuRC complex, is a direct interaction partner of CM14. CM14 overcomes ALK inhibitor resistance in ALCL and is also active in T-cell Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia. Interestingly, CM14 also induced cell death in docetaxel-resistant prostate cancer cells thus suggesting an unexpected role in solid cancers. Thus, we synthesized and thoroughly characterized a novel TUBGCP2 targeting drug that is active in ALCL but has also potential for other
malignancies.</dc:description>

  
<datacite:subjects>
  
<datacite:subject xml:lang="en">Humans</datacite:subject>

  
<datacite:subject xml:lang="en">Caffeic Acids Pharmacology</datacite:subject>

  
<datacite:subject xml:lang="en">Caffeic Acids Chemistry</datacite:subject>

  
<datacite:subject xml:lang="en">Phenylethyl Alcohol Analogs &amp; Derivatives</datacite:subject>

  
<datacite:subject xml:lang="en">Phenylethyl Alcohol Pharmacology</datacite:subject>

  
<datacite:subject xml:lang="en">Phenylethyl Alcohol Chemistry</datacite:subject>

  
<datacite:subject xml:lang="en">Centrosome Drug Effects</datacite:subject>

  
<datacite:subject xml:lang="en">Centrosome Metabolism</datacite:subject>

  
<datacite:subject xml:lang="en">Antineoplastic Agents Pharmacology</datacite:subject>

  
<datacite:subject xml:lang="en">Antineoplastic Agents Chemistry</datacite:subject>

  
<datacite:subject xml:lang="en">Apoptosis Drug Effects</datacite:subject>

  
<datacite:subject xml:lang="en">Cell Line, Tumor</datacite:subject>

  
<datacite:subject xml:lang="en">Cell Proliferation Drug Effects</datacite:subject>

  
</datacite:subjects>

  
<licenseCondition uri="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</licenseCondition>

  
<file accessRightsURI="http://purl.org/coar/access_right/c_abf2" mimeType="application/pdf" objectType="fulltext">https://phaidra.vetmeduni.ac.at/api/object/o:4027/download</file>

  
<datacite:alternateIdentifiers>
  
<datacite:alternateIdentifier alternateIdentifierType="DOI">10.1016/j.redox.2025.103582</datacite:alternateIdentifier>

  
</datacite:alternateIdentifiers>

  
<datacite:relatedIdentifiers>
  
<datacite:relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf">https://phaidra.vetmeduni.ac.at/o:605</datacite:relatedIdentifier>

  
</datacite:relatedIdentifiers>

  
<dc:format>application/pdf</dc:format>

  
<dc:source xml:lang="en">Redox Biology</dc:source>

  
<dc:source>issn:2213-2317</dc:source>

  
<version uri="http://purl.org/coar/version/c_970fb48d4fbd8a85">VoR</version>

  
<citationTitle>Redox Biology</citationTitle>

  
<citationVolume>81</citationVolume>

  
<datacite:sizes>
  
<datacite:size>5.54 MB</datacite:size>

  
</datacite:sizes>

  
<datacite:dates>
  
<datacite:date dateType="Issued">2025</datacite:date>

  
</datacite:dates>

  
</resource>


